CD8A and neoplasm: Notably, the TCR effectively redirected both CD4<sup>+</sup> and CD8<sup>+</sup> T cells to specifically recognize tumor cells and induced multiple cytokine secretion along with durable antitumor activity and outstanding safety profiles.